Correction to: Strategies for Predicting Response to Checkpoint Inhibitors.

Journal

Current hematologic malignancy reports
ISSN: 1558-822X
Titre abrégé: Curr Hematol Malig Rep
Pays: United States
ID NLM: 101262565

Informations de publication

Date de publication:
Feb 2019
Historique:
pubmed: 9 11 2018
medline: 9 11 2018
entrez: 9 11 2018
Statut: ppublish

Résumé

The original version of this article unfortunately contained a mistake. The conflict of interest statement was incorrect. The corrected statement is given below.

Identifiants

DOI: 10.1007/s11899-018-0488-0 PMID: 30406880
pubmed: 30406880
doi: 10.1007/s11899-018-0488-0
pii: 10.1007/s11899-018-0488-0
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

62

Commentaires et corrections

Type : ErratumFor

Auteurs

Roberta Zappasodi (R)

Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.

Jedd D Wolchok (JD)

Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.
Weill Cornell Medicine, New York, NY, 10065, USA.

Taha Merghoub (T)

Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. merghout@mskcc.org.
Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. merghout@mskcc.org.
Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA. merghout@mskcc.org.

Classifications MeSH